Integer Holdings Corp 2026年季度报告

FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2026 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INTEGER HOLDINGS CORPORATION(Exact name of Registrant as specified in its charter)_____________________________________________________________ Delaware 16-1531026 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 5830 Granite Parkway,Suite 1150Plano, Texas 75024(Zip Code) (214) 618-5243(Registrant’s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock, $0.001 par value per shareITGRNew York Stock Exchange Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2)has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Acceleratedfiler☐Non-accelerated filerSmallerreportingcompany☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ The number of shares outstanding of the Company’s common stock, $0.001 par value per share, as of July30, 2026 was: 33,992,048shares. INTEGER HOLDINGS CORPORATIONForm 10-QFor the Quarterly Period Ended July3, 2026 TABLE OF CONTENTS PART I—FINANCIAL INFORMATION ITEM 1.Financial Statements3Condensed Consolidated Balance Sheets (Unaudited)3Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)4Condensed Consolidated Statements of Cash Flows (Unaudited)5Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)6Notes to Condensed Consolidated Financial Statements (Unaudited)7ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations33ITEM 3.Quantitative and Qualitative Disclosures About Market Risk51ITEM 4.Controls and Procedures51 ITEM 1.Legal ProceedingsITEM 1A.Risk Factors ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds53ITEM 5.Other Information53ITEM 6.Exhibits54SIGNATURES55 PART I—FINANCIAL INFORMATION INTEGER HOLDINGS CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) INTEGER HOLDINGS CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) INTEGER HOLDINGS CORPORATIONNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (1.)BASIS OF PRESENTATION Integer Holdings Corporation (together with its consolidated subsidiaries, “Integer” or the “Company”) is a publicly-tradedcorporation listed on the New York Stock Exchange under the symbol “ITGR.” Integer is a medical device contract development andmanufacturing organization, primarily serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets.The Company’s primary customers include large, multi-national original equipment manufacturers (“OEMs”) and their affiliatedsubsidiaries. The accompanying condensed consolidated financial statements are presented in accordance with the rules and regulations of theUnited States (“U.S.”) Securities and Exchange Commission (“SEC”) and do not include all of the disclosures normally required byU.S. generally accepted accounting principles (“U.S. GAAP”) as contained in the Company’s Annual Report on Form 10-K.Accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financialstatements and notes thereto included in the Company’s most recent Annual Report on Form 10-K for the year ended December31,2025. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of normal recurringadjustments) considered necessary for a fair presentation of the res